Skip to main content
Erschienen in: Current Pain and Headache Reports 4/2018

01.04.2018 | Other Pain (A Kaye and N Vadivelu, Section Editors)

Spinal Cord Stimulation, MILD Procedure, and Regenerative Medicine, Novel Interventional Nonopioid Therapies in Chronic Pain

verfasst von: Ken P. Ehrhardt Jr, Susan M. Mothersele, Andrew J. Brunk, Jeremy B. Green, Mark R. Jones, Craig B. Billeaud, Alan David Kaye

Erschienen in: Current Pain and Headache Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Chronic pain is a highly prevalent condition affecting millions of individuals.

Recent Findings

In recent years, newer treatments have emerged that are changing the way clinicians treat pain pathogenesis, including novel nonopioid strategies. In this regard, spinal cord stimulation, the MILD procedure, and regenerative medicine have shown promise. This review summarizes recent literature on these three emerging treatment strategies.

Summary

The results of this review suggest that under certain conditions, spinal cord stimulation, the MILD procedure, and regenerative medicine can be effective treatment modalities.
Literatur
1.
Zurück zum Zitat Kapural L. Spinal cord stimulation for intractable chronic pain. Curr Pain Headache Rep. 2014;18(4):406.CrossRefPubMed Kapural L. Spinal cord stimulation for intractable chronic pain. Curr Pain Headache Rep. 2014;18(4):406.CrossRefPubMed
2.
Zurück zum Zitat Xu J, Liu A, Cheng J. New advancements in spinal cord stimulation for chronic pain management. Curr Opin Anaesthesiol. 2017;30(6):710–7.CrossRefPubMed Xu J, Liu A, Cheng J. New advancements in spinal cord stimulation for chronic pain management. Curr Opin Anaesthesiol. 2017;30(6):710–7.CrossRefPubMed
3.
Zurück zum Zitat Zhang TC, Janik JJ, Grill WM. Modeling effects of spinal cord stimulation on wide-dynamic range dorsal horn neurons: influence of stimulation frequency and GABAergic inhibition. J Neurophysiol. 2014;112(3):552–67.CrossRefPubMed Zhang TC, Janik JJ, Grill WM. Modeling effects of spinal cord stimulation on wide-dynamic range dorsal horn neurons: influence of stimulation frequency and GABAergic inhibition. J Neurophysiol. 2014;112(3):552–67.CrossRefPubMed
4.
Zurück zum Zitat Kapural L, Peterson E, Provenzano DA, Staats P. Clinical evidence for spinal cord stimulation for failed back surgery syndrome (FBSS): systematic review. Spine (Phila Pa 1976). 2017 Jul 15;42(Suppl 14):S61–6.CrossRef Kapural L, Peterson E, Provenzano DA, Staats P. Clinical evidence for spinal cord stimulation for failed back surgery syndrome (FBSS): systematic review. Spine (Phila Pa 1976). 2017 Jul 15;42(Suppl 14):S61–6.CrossRef
5.
Zurück zum Zitat Kumar K, Buchser E, Linderoth B, Meglio M, Van Buyten JP. Avoiding complications from spinal cord stimulation: practical recommendations from an international panel of experts. Neuromodulation. 2007;10(1):24–33.CrossRefPubMed Kumar K, Buchser E, Linderoth B, Meglio M, Van Buyten JP. Avoiding complications from spinal cord stimulation: practical recommendations from an international panel of experts. Neuromodulation. 2007;10(1):24–33.CrossRefPubMed
6.
Zurück zum Zitat Rudiger J, Thomson S. Infection rate of spinal cord stimulators after a screening trial period. A 53-month third party follow-up. Neuromodulation. 2011;14(2):136–41.CrossRefPubMed Rudiger J, Thomson S. Infection rate of spinal cord stimulators after a screening trial period. A 53-month third party follow-up. Neuromodulation. 2011;14(2):136–41.CrossRefPubMed
7.
Zurück zum Zitat Smith CC, Lin JL, Shokat M, Dosanjh SS, Casthely D. A report of paraparesis following spinal cord stimulator trial, implantation and revision. Pain Physician. 2010;13(4):357–63.PubMed Smith CC, Lin JL, Shokat M, Dosanjh SS, Casthely D. A report of paraparesis following spinal cord stimulator trial, implantation and revision. Pain Physician. 2010;13(4):357–63.PubMed
8.
Zurück zum Zitat Kalichman L, Cole R, Kim DH, Li L, Suri P, Guermazi A, et al. Spinal stenosis prevalence and association with symptoms: the Framingham study. Spine J. 2009;9(7):545–50.CrossRefPubMedPubMedCentral Kalichman L, Cole R, Kim DH, Li L, Suri P, Guermazi A, et al. Spinal stenosis prevalence and association with symptoms: the Framingham study. Spine J. 2009;9(7):545–50.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat •• Deer TR, Kapural L. New image-guided ultra-minimally invasive lumbar decompression method: the mild procedure. Pain Physician. 2010;13(1):35–41. excellent description of the mild procedure. PubMed •• Deer TR, Kapural L. New image-guided ultra-minimally invasive lumbar decompression method: the mild procedure. Pain Physician. 2010;13(1):35–41. excellent description of the mild procedure. PubMed
10.
Zurück zum Zitat Schomer DF, Solsberg D, Wong W, Chopko BW. Mild® lumbar decompression for the treatment of lumbar spinal stenosis. Neuroradiol J. 2011;24:620–6.CrossRefPubMed Schomer DF, Solsberg D, Wong W, Chopko BW. Mild® lumbar decompression for the treatment of lumbar spinal stenosis. Neuroradiol J. 2011;24:620–6.CrossRefPubMed
11.
12.
Zurück zum Zitat Mekhail N, Vallejo R, Coleman MH, Benyamin RM. Long-term results of percutaneous lumbar decompression mild for spinal stenosis. Pain Pract. 2012;12:184–93.CrossRefPubMed Mekhail N, Vallejo R, Coleman MH, Benyamin RM. Long-term results of percutaneous lumbar decompression mild for spinal stenosis. Pain Pract. 2012;12:184–93.CrossRefPubMed
13.
Zurück zum Zitat Chopko BW. Long-term results of percutaneous lumbar decompression for LSS: two-year outcomes. Clin J Pain. 2013;29(11):939–43.CrossRefPubMed Chopko BW. Long-term results of percutaneous lumbar decompression for LSS: two-year outcomes. Clin J Pain. 2013;29(11):939–43.CrossRefPubMed
14.
Zurück zum Zitat Kreiner DS, MacVicar J, Duszynski B, Nampiaparampil DE. The mild procedure: a systematic review of the current literature. Pain Med. 2014;15:196–205.CrossRefPubMed Kreiner DS, MacVicar J, Duszynski B, Nampiaparampil DE. The mild procedure: a systematic review of the current literature. Pain Med. 2014;15:196–205.CrossRefPubMed
15.
Zurück zum Zitat Staats PS, Benyamin RM, MiDAS ENCORE Investigators. MiDAS ENCORE: randomized controlled clinical trial report of 6-month results. Pain Physician. 2016;19(2):25–38.PubMed Staats PS, Benyamin RM, MiDAS ENCORE Investigators. MiDAS ENCORE: randomized controlled clinical trial report of 6-month results. Pain Physician. 2016;19(2):25–38.PubMed
16.
Zurück zum Zitat Benyamin RM, Staats PS, MiDAS Encore I. MILD is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE randomized controlled trial. Pain Physician. 2016;19:229–42.PubMed Benyamin RM, Staats PS, MiDAS Encore I. MILD is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE randomized controlled trial. Pain Physician. 2016;19:229–42.PubMed
18.
Zurück zum Zitat Arai Y, Hirai T, Yoshii T, Sakai K, Kato T, Enomoto M, et al. A prospective comparative study of 2 minimally invasive decompression procedures for lumbar spinal canal stenosis: unilateral laminotomy for bilateral decompression (ULBD) versus muscle-preserving interlaminar decompression (MILD). Spine (Phila Pa 1976). 2014;39(4):332–40. https://doi.org/10.1097/BRS.0000000000000136.CrossRef Arai Y, Hirai T, Yoshii T, Sakai K, Kato T, Enomoto M, et al. A prospective comparative study of 2 minimally invasive decompression procedures for lumbar spinal canal stenosis: unilateral laminotomy for bilateral decompression (ULBD) versus muscle-preserving interlaminar decompression (MILD). Spine (Phila Pa 1976). 2014;39(4):332–40. https://​doi.​org/​10.​1097/​BRS.​0000000000000136​.CrossRef
21.
Zurück zum Zitat •• Siniscalco D, Rossi F, Maione S. Stem cell therapy for neuropathic pain treatment. J Stem Cells Regen Med. 2007;3(1):2–11. excellent description of the stem cell therapy for neuropathic pain treatment. PubMedPubMedCentral •• Siniscalco D, Rossi F, Maione S. Stem cell therapy for neuropathic pain treatment. J Stem Cells Regen Med. 2007;3(1):2–11. excellent description of the stem cell therapy for neuropathic pain treatment. PubMedPubMedCentral
22.
23.
Zurück zum Zitat Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington (DC): National Academies Press (US); 2011. 2, pain as a public health challenge Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington (DC): National Academies Press (US); 2011. 2, pain as a public health challenge
25.
Zurück zum Zitat Klass M, Gavrikov V, Drury D, Stewart B, Hunter S, Denson DD, et al. Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy. Anesth Analg. 2007;104(4):944–8.CrossRefPubMed Klass M, Gavrikov V, Drury D, Stewart B, Hunter S, Denson DD, et al. Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy. Anesth Analg. 2007;104(4):944–8.CrossRefPubMed
26.
Zurück zum Zitat Schultz SS. Adult stem cell application in spinal cord injury. Curr Drug Targets. 2005;6:63–73.CrossRefPubMed Schultz SS. Adult stem cell application in spinal cord injury. Curr Drug Targets. 2005;6:63–73.CrossRefPubMed
27.
Zurück zum Zitat Klein S, Svendsen CN. Stem cells in the injured spinal cord: reducing the pain and increasing the gain. Nat Neurosci. 2005;8:259–60.CrossRefPubMed Klein S, Svendsen CN. Stem cells in the injured spinal cord: reducing the pain and increasing the gain. Nat Neurosci. 2005;8:259–60.CrossRefPubMed
28.
Zurück zum Zitat Hains BC, Johnson KM, Eaton MJ, Willis WD, Hulsebosch CE. Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat. Neuroscience. 2003;116:1097–110.CrossRefPubMed Hains BC, Johnson KM, Eaton MJ, Willis WD, Hulsebosch CE. Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat. Neuroscience. 2003;116:1097–110.CrossRefPubMed
29.
Zurück zum Zitat Bonfield TL, Caplan AI. Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. Discov Med. 2010;9(47):337–45.PubMed Bonfield TL, Caplan AI. Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. Discov Med. 2010;9(47):337–45.PubMed
30.
Zurück zum Zitat •• Hsu WK, Mishra A, Rodeo SR, et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2013;21:739–48. excellent evidence-based recommendations for platelet-rich plasma in orthopaedic applications. PubMed •• Hsu WK, Mishra A, Rodeo SR, et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2013;21:739–48. excellent evidence-based recommendations for platelet-rich plasma in orthopaedic applications. PubMed
34.
Zurück zum Zitat Arnoczky SP, Delos D, Rodeo SA. What is platelet-rich plasma? Oper Tech Sports Med. 2011;19:142–8.CrossRef Arnoczky SP, Delos D, Rodeo SA. What is platelet-rich plasma? Oper Tech Sports Med. 2011;19:142–8.CrossRef
35.
Zurück zum Zitat Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leukocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158–67.CrossRefPubMed Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leukocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158–67.CrossRefPubMed
36.
Zurück zum Zitat Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94:308–16.CrossRefPubMed Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94:308–16.CrossRefPubMed
37.
Zurück zum Zitat Marx RE. Platelet-rich plasma (PRP). What is PRP and what is not PRP? Implant Dent. 2001;10:225–8.CrossRefPubMed Marx RE. Platelet-rich plasma (PRP). What is PRP and what is not PRP? Implant Dent. 2001;10:225–8.CrossRefPubMed
38.
Zurück zum Zitat Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37:2259–72.CrossRefPubMed Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37:2259–72.CrossRefPubMed
40.
Zurück zum Zitat Alsousou J, Thompson M, Hulley P, et al. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br. 2009;91:987–96.CrossRefPubMed Alsousou J, Thompson M, Hulley P, et al. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br. 2009;91:987–96.CrossRefPubMed
41.
42.
Zurück zum Zitat Cerza F, Carni S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40:2822–7.CrossRefPubMed Cerza F, Carni S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40:2822–7.CrossRefPubMed
43.
Zurück zum Zitat Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double- blind, randomized trial. Am J Sports Med. 2013;41:356–64.CrossRefPubMed Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double- blind, randomized trial. Am J Sports Med. 2013;41:356–64.CrossRefPubMed
44.
Zurück zum Zitat Filardo G, Kon E, Di Martino A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012;13:229.CrossRefPubMedPubMedCentral Filardo G, Kon E, Di Martino A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012;13:229.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Kanchanatawan W, Arirachakaran A, Chaijenkij K, Prasathaporn N, Boonard M, Piyapittayanun P, et al. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc: Off J ESSKA. 2016;24(5):1665–77.CrossRef Kanchanatawan W, Arirachakaran A, Chaijenkij K, Prasathaporn N, Boonard M, Piyapittayanun P, et al. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc: Off J ESSKA. 2016;24(5):1665–77.CrossRef
46.
Zurück zum Zitat Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1- year follow-up. Am J Sports Med. 2010;38:255–62.CrossRefPubMed Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1- year follow-up. Am J Sports Med. 2010;38:255–62.CrossRefPubMed
47.
Zurück zum Zitat Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper’s knee. Int Orthop. 2010;34:909–15.CrossRefPubMed Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper’s knee. Int Orthop. 2010;34:909–15.CrossRefPubMed
48.
Zurück zum Zitat Gosens T, Den Oudsten BL, Fievez E, ‘t v, Spijker P, Fievez A. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int Orthop. 2012;36:1941–6.CrossRefPubMedPubMedCentral Gosens T, Den Oudsten BL, Fievez E, ‘t v, Spijker P, Fievez A. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int Orthop. 2012;36:1941–6.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat de Vos RJ, Weir A, van Schie HTM, Bierma-Zeinstra SMA, Verhaar JAN, Weinans H, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy a randomized controlled trial. JAMA. 2010;303(2):144–9.CrossRefPubMed de Vos RJ, Weir A, van Schie HTM, Bierma-Zeinstra SMA, Verhaar JAN, Weinans H, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy a randomized controlled trial. JAMA. 2010;303(2):144–9.CrossRefPubMed
50.
Zurück zum Zitat Emel E, Ergun SS, Kotan D, et al. Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a rat model. J Neurosurg. 2011;114:522–8.CrossRefPubMed Emel E, Ergun SS, Kotan D, et al. Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a rat model. J Neurosurg. 2011;114:522–8.CrossRefPubMed
51.
Zurück zum Zitat Elgazzar RF, Mutabagani MA, Abdelaal SE, Sadakah AA. Platelet-rich plasma may enhance peripheral nerve regeneration after cyanoacrylate reanasto- mosis: a controlled blind study on rats. Int J Oral Maxillofac Surg. 2008;37:748–55.CrossRefPubMed Elgazzar RF, Mutabagani MA, Abdelaal SE, Sadakah AA. Platelet-rich plasma may enhance peripheral nerve regeneration after cyanoacrylate reanasto- mosis: a controlled blind study on rats. Int J Oral Maxillofac Surg. 2008;37:748–55.CrossRefPubMed
52.
Zurück zum Zitat Yu W, Wang J, Yin J. Platelet-rich plasma: a promising product for treatment of peripheral nerve regeneration after nerve injury. Int J Neurosci. 2011;121:176–80.CrossRefPubMed Yu W, Wang J, Yin J. Platelet-rich plasma: a promising product for treatment of peripheral nerve regeneration after nerve injury. Int J Neurosci. 2011;121:176–80.CrossRefPubMed
53.
Zurück zum Zitat Cho HH, Jang S, Lee SC, Jeong HS, Park JS, Han JY, et al. Effect of neural-induced mesenchymal stem cells and platelet-rich plasma on facial nerve regeneration in an acute nerve injury model. Laryngoscope. 2010;120:907–13.CrossRefPubMed Cho HH, Jang S, Lee SC, Jeong HS, Park JS, Han JY, et al. Effect of neural-induced mesenchymal stem cells and platelet-rich plasma on facial nerve regeneration in an acute nerve injury model. Laryngoscope. 2010;120:907–13.CrossRefPubMed
54.
Zurück zum Zitat Kuffler DP. Platelet-rich plasma and the elimination of neuropathic pain. Mol Neurobiol. 2013;48:315–32.CrossRefPubMed Kuffler DP. Platelet-rich plasma and the elimination of neuropathic pain. Mol Neurobiol. 2013;48:315–32.CrossRefPubMed
55.
Zurück zum Zitat Li P, Zhang R, Zhou Q. Efficacy of platelet-rich plasma in retarding intervertebral disc degeneration: a meta-analysis of animal studies. BioMed Res Int. 2017;2017:7919201, 10 pages.PubMedPubMedCentral Li P, Zhang R, Zhou Q. Efficacy of platelet-rich plasma in retarding intervertebral disc degeneration: a meta-analysis of animal studies. BioMed Res Int. 2017;2017:7919201, 10 pages.PubMedPubMedCentral
56.
Zurück zum Zitat Chen WH, Lo WC, Lee JJ, Su CH, Lin CT, Liu HY, et al. Tissue-engineered intervertebral disc and chon- drogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol. 2006;209:744–54.CrossRefPubMed Chen WH, Lo WC, Lee JJ, Su CH, Lin CT, Liu HY, et al. Tissue-engineered intervertebral disc and chon- drogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol. 2006;209:744–54.CrossRefPubMed
57.
Zurück zum Zitat Akeda K, An HS, Pichika R, Attawia M, Thonar EJMA, Lenz ME, et al. Platelet-rich plasma (PRP) stimulates the extra- cellular matrix metabolism of porcine nucleus pulposus and annulus fibrosus cells cultured in alginate beads. Spine. 2006;31:959–66.CrossRefPubMed Akeda K, An HS, Pichika R, Attawia M, Thonar EJMA, Lenz ME, et al. Platelet-rich plasma (PRP) stimulates the extra- cellular matrix metabolism of porcine nucleus pulposus and annulus fibrosus cells cultured in alginate beads. Spine. 2006;31:959–66.CrossRefPubMed
Metadaten
Titel
Spinal Cord Stimulation, MILD Procedure, and Regenerative Medicine, Novel Interventional Nonopioid Therapies in Chronic Pain
verfasst von
Ken P. Ehrhardt Jr
Susan M. Mothersele
Andrew J. Brunk
Jeremy B. Green
Mark R. Jones
Craig B. Billeaud
Alan David Kaye
Publikationsdatum
01.04.2018
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 4/2018
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-018-0680-x

Weitere Artikel der Ausgabe 4/2018

Current Pain and Headache Reports 4/2018 Zur Ausgabe

Childhood and Adolescent Headache (S Evers, Section Editor)

Cyclic Vomiting Syndrome in Children

Other Pain (A Kaye and N Vadivelu, Section Editors)

Novel Pharmacological Nonopioid Therapies in Chronic Pain

Other Pain (A Kaye and N Vadivelu, Section Editors)

Novel Interventional Nonopioid Therapies in Headache Management

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.